139 related articles for article (PubMed ID: 35723079)
1. The prognostic impact of myosteatosis on overall survival in gynecological cancer patients: A meta-analysis and trial sequential analysis.
Cao H; Gong Y; Wang Y
Int J Cancer; 2022 Dec; 151(11):1997-2003. PubMed ID: 35723079
[TBL] [Abstract][Full Text] [Related]
2. Myosteatosis reduces overall survival in patients with digestive system malignancies: a meta-analysis with trial sequential analysis.
Wang Y; Tian G; Chen S; Li N
Nutr Res; 2021 Oct; 94():25-33. PubMed ID: 34583210
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of myosteatosis for overall survival in patients with gastric cancers: A meta-analysis with trial sequential analysis.
Fang T; Gong Y; Wang Y
Nutrition; 2023 Jan; 105():111866. PubMed ID: 36368263
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis.
Feng S; Mu H; Hou R; Liu Y; Zou J; Zhao Z; Zhu Y
Int J Clin Oncol; 2022 Jul; 27(7):1127-1138. PubMed ID: 35604501
[TBL] [Abstract][Full Text] [Related]
5. Myosteatosis and prognosis in cancer: Systematic review and meta-analysis.
Aleixo GFP; Shachar SS; Nyrop KA; Muss HB; Malpica L; Williams GR
Crit Rev Oncol Hematol; 2020 Jan; 145():102839. PubMed ID: 31877534
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis.
Lee CM; Kang J
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1270-1282. PubMed ID: 32483936
[TBL] [Abstract][Full Text] [Related]
7. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
Zhang C; Yang Q
Front Oncol; 2020; 10():572203. PubMed ID: 33634012
[TBL] [Abstract][Full Text] [Related]
8. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
9. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
[TBL] [Abstract][Full Text] [Related]
10. The impact of myosteatosis on outcomes following surgery for gastrointestinal malignancy: a meta-analysis.
MacCormick A; Streeter A; Puckett M; Aroori S
Ann R Coll Surg Engl; 2023 Mar; 105(3):203-211. PubMed ID: 35175107
[TBL] [Abstract][Full Text] [Related]
11. Assessment of myosteatosis and functionality in pretreatment gynecological cancer patients.
da Silva RC; Chaves GV; Bergmann A; Frajacomo FTT
Support Care Cancer; 2024 May; 32(6):339. PubMed ID: 38733544
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytosis in gynecological cancers.
Sharma D; Singh G
J Cancer Res Ther; 2017; 13(2):193-197. PubMed ID: 28643732
[TBL] [Abstract][Full Text] [Related]
13. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
14. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.
Li J; Liu R; Tang S; Feng F; Liu C; Wang L; Zhao W; Zhang T; Yao Y; Wang X; Sun C
Arch Gynecol Obstet; 2019 Jan; 299(1):35-46. PubMed ID: 30460611
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with ovarian cancer: A systematic review and meta-analysis.
Yin X; Wu L; Yang H; Yang H
Medicine (Baltimore); 2019 Nov; 98(45):e17475. PubMed ID: 31702609
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis.
Lu J; Gu Y; Li Q; Zhong H; Wang X; Zheng Z; Hu W; Wen L
Medicine (Baltimore); 2018 Jul; 97(28):e11485. PubMed ID: 29995811
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and Clinicopathological Significance of ARID1A in Endometrium-Related Gynecological Cancers: A Meta-Analysis.
Liu G; Xu P; Fu Z; Hua X; Liu X; Li W; Zhang M; Wu J; Wen J; Xu J; Jia X
J Cell Biochem; 2017 Dec; 118(12):4517-4525. PubMed ID: 28466574
[TBL] [Abstract][Full Text] [Related]
18. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort.
Zhuang CL; Shen X; Huang YY; Zhang FM; Chen XY; Ma LL; Chen XL; Yu Z; Wang SL
Surgery; 2019 Sep; 166(3):297-304. PubMed ID: 31072665
[TBL] [Abstract][Full Text] [Related]
19. The prognostic nutritional index is prognostic factor of gynecological cancer: A systematic review and meta-analysis.
Wang X; Wang Y
Int J Surg; 2019 Jul; 67():79-86. PubMed ID: 31185310
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
